21 /100
LOW RISK
Score updated Jul 13, 2026

LGND — Ligand Pharmaceuticals Incorporated Dilution Risk Tracker

Track LGND dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LGND — Get alerts when the score changes →

As of July 13, 2026, Ligand Pharmaceuticals Incorporated (LGND) has a DilutionWatch DilutionScore of 21/100, rated LOW dilution risk. Ligand Pharmaceuticals Incorporated has a market capitalization of $4.65B, 20.04M shares outstanding, 360 institutional holders tracked. Key dilution vectors include 3.26M outstanding warrants, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
50
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
17%
📜 Warrant Exercise 25%
• Significant warrants: 16% of shares outstanding
🔁 Convertible Conversion 15%
• Convertible debt present: 9.9% potential dilution
🔔 Track LGND — Get forecast alerts →

💹 Market Data

Market Cap$4.65B
Shares Outstanding20.04M
Float19.57M
Cash$779.40M
Debt$27.50M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 15.2% shares (2026Q1 vs prior)
360 institutional holders · 24.14M shares
#1 BlackRock, Inc. 2.96M shares
#2 JANUS HENDERSON GROUP PLC 2.02M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.70M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.12M
Days to Cover2.6
% of Float10.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2023
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for LGND Shareholders

Ligand Pharmaceuticals Incorporated (LGND) has a DilutionScore of 21/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch tracks 3.3M outstanding warrants for LGND. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for LGND in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LGND alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track LGND Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LGND — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LGND
📊 LGND FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LGND Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.